New Research Eases Fears About GLP-1 Medications and Thyroid Cancer
For years, people taking GLP-1 receptor agonists (GLP-1 RAs)—such as semaglutide (Ozempic, Wegovy) and liraglutide (Victoza, Saxenda)—have been warned about a potential risk of…
For years, people taking GLP-1 receptor agonists (GLP-1 RAs)—such as semaglutide (Ozempic, Wegovy) and liraglutide (Victoza, Saxenda)—have been warned about a potential risk of…
Obesity is a growing global health concern, affecting millions of people worldwide. According to the World Health Organization (WHO) 2022…
Obesity (Sthoulya or Medoroga) is considered an imbalance of Kapha and Medo Dhatu (fat tissue) in Ayurveda. It is caused…
Why Do We Gain Weight So Easily? For most of human history, food scarcity was a bigger threat than overeating.…
In recent months, a surprising combination has been making waves in the health and wellness world: oatmeal and Ozempic. This…
Obesity, defined by a Body Mass Index (BMI) of 30 or higher, is a pressing global health issue. According to…
GLP-1 receptor agonists have revolutionized diabetes and obesity management, offering new hope for patients worldwide. These drugs mimic the incretin…